Phendimetrazine Tartrate 35 mg, 105 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 35 mg, 105 mg

Reference Brands: Bontril (USA), Plegine (USA)

Category: Weight Loss drugs

Phendimetrazine tartrate is a stimulant appetite suppressant for short-term weight loss in obesity, alongside diet and exercise. It comes as 35 mg tablets and 105 mg extended-release capsules; reference brands include Bontril. It is a controlled substance (Schedule III in the US). It is a controlled medicine in most countries, so we check the buyer's import permits before quoting.

Product Description:

Phendimetrazine tartrate is a sympathomimetic amine and an amphetamine congener, marketed under brand names such as Bontril, Plegine, and Prelu-2. It is used as a short-term appetite suppressant to assist in the management of obesity in adults as part of a comprehensive weight loss program that includes diet, exercise, and behavioral modification.

Structurally related to methamphetamine, phendimetrazine functions as a prodrug for phenmetrazine, its active metabolite. This unique metabolic pathway provides more favorable pharmacokinetics compared to phenmetrazine, producing a steady and prolonged release of the active compound in the body. This results in a lower peak blood concentration of phenmetrazine, reducing the potential for abuse while maintaining therapeutic efficacy. By stimulating the central nervous system, phendimetrazine suppresses appetite, helping patients control caloric intake and promote weight loss safely under medical supervision.

Phendimetrazine’s controlled-release profile and prodrug design make it an effective and safer alternative to direct phenmetrazine administration, allowing for regulated therapeutic action and improved compliance. It is intended strictly for short-term use and must be administered under professional guidance due to its stimulant properties and potential side effects.